Mulmit

Cardiff Oncology, Inc.Cardiff Oncology, Inc.

CRDF Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-31593,000-48,960,000-45,851-0.69
2024-12-31683,000-48,651,000-45,431-0.95
2023-12-31488,000-45,412,000-41,441-0.93
2022-12-31386,000-39,902,000-38,704,000-0.89
2021-12-31359,000-28,855,000-28,291,000-0.73

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-07-14PACE GARY W687,285
2026-07-14PACE GARY W687,285
2026-07-14Mohindru ManiChief Executive Officer34,364
2026-07-14Mohindru ManiChief Executive Officer34,364
2026-06-18Mohindru ManiChief Executive Officer24,703
2026-06-18PACE GARY W30,000
2026-06-11White Lale40,565
2026-06-11TANNENBAUM RENEE P40,565
2026-06-11Markin Rodney S40,565
2026-06-11Armitage James O40,565
2026-06-11PACE GARY W40,565
2026-04-27Aggarwal AjayChief Operating Officer400,000

8-K events

FiledItems
2026-09-14Entry into a material agreement · Regulation FD disclosure · Financial statements and exhibits
2026-08-11Results of operations · Financial statements and exhibits
2026-07-16Entry into a material agreement · Other events · Financial statements and exhibits
2026-06-11Submission of matters to a vote
2026-06-03Regulation FD disclosure
2026-05-29Entry into a material agreement
2026-05-19Other events
2026-05-14Results of operations · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.